BOULDER, Colo., Jan. 3, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference in San Francisco. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: |
Annual J.P. Morgan Healthcare Conference |
Presenter: |
Ron Squarer, Chief Executive Officer, Array BioPharma |
Date: |
Wednesday, January 11, 2017 |
Time: |
8:30 a.m. Pacific Time |
Location: |
Westin St. Francis Hotel, San Francisco |
Webcast: |
http://jpmorgan.metameetings.com/confbook/healthcare17/directlink?p=22698 |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca).
CONTACT: |
Tricia Haugeto |
Array BioPharma Inc. |
|
303-386-1193 |
|
SOURCE Array BioPharma
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article